Allarity Therapeutics
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | |||
EBITDA | -3,036 | -7,377 | -12,313 | -1,202 |
EBIT | -7,378 | -12,318 | -1,203 | |
Net Income | -2,732 | -7,453 | -12,152 | -1,629 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,686 | -3,504 | -5,443 | -7,216 |
Cash | 25,201 | 19,533 | 18,463 | 19,233 |
Basic Shares | 1,114 | 1,575 | 1,575 | 499 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -37 | -120 | -106 | |
EBITDA | -27,241 | -12,083 | -17,236 | -25,910 |
EBIT | -25,549 | -12,120 | -17,356 | -26,016 |
Net Income | -24,515 | -11,901 | -16,058 | -26,648 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -17,337 | |||
Free Cash Flow | -17,650 | -12,745 | -16,835 | -15,050 |
Cash | 19,533 | 166 | 2,029 | 19,555 |
Basic Shares | 1,575 | 1,990 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.15 |
2025-03-31 | -$0.25 |
2024-12-31 | -$1.72 |
2024-09-30 | -$1.74 |
